Oragenics, Inc (OGEN) Stock Price

0.5363 ▼ -0.0126 (-2.30%)
Open: 0.524 Vol: 13.49K Day's range: 0.5226 - 0.55 Aug 12, 16:00 EDT
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
OGEN Technical Analysis
5 mins 30 mins Hourly Daily Weekly
NEUTRAL SELL SELL SELL SELL
  5 mins 30 mins Hourly Daily Weekly
MA5 0.54▲ 0.54▲ 0.54▲ 0.55▼ 0.53▲
MA10 0.53▲ 0.53▲ 0.53▲ 0.53▲ 0.56▼
MA20 0.55▼ 0.55▼ 0.55▼ 0.53▲ 0.58▼
MA50 0.58▼ 0.58▼ 0.58▼ 0.57▼ 0.81▼
MA100 0.59▼ 0.59▼ 0.60▼ 0.59▼ 0.79▼
MA200 0.62▼ 0.61▼ 0.63▼ 0.75▼ 2.41▼
  5 mins 30 mins Hourly Daily Weekly
MACD 0.001▲ 0.000▲ 0.000▲ 0.006▲ 0.009▲
RSI 47.016▼ 46.728▼ 46.725▼ 47.223▼ 40.672▼
STOCH 84.100▲ 65.163     65.163     78.479     26.094    
WILL %R -10.000▲ -45.592     -45.592     -31.713     -63.974    
CCI 46.952     20.119     20.119     51.263     -91.563    
Latest Filters Detected On OGEN
RSI $OGEN RSI(14) Crossed Below 50 Set Alert
MA $OGEN Price Crossed Below MA(26) Set Alert
MA $OGEN Price Crossed Below MA(7) Set Alert
▼ GAP $OGEN Open Gap Down %3 Set Alert
▼ GAP $OGEN Open Gap Down %2 Set Alert
Oragenics, Inc News
Biomednewsbreaks - Oragenics Inc. (NYSE American: OGEN) Activates All Australian Phase Iia Trial Sites For ONP-002
Monday, July 06, 2026 07:06 PM
(MENAFN- Investor Brand Network) Oragenics (NYSE American: OGEN) announced that all three sites in its Australian Phase IIa clinical trial of ONP-002 for mild traumatic brain injury (concussion) are ...
Investornewsbreaks Oragenics Inc. (NYSE American: OGEN) To Present At Sidoti Micro-Cap Virtual Investor Conference
Monday, May 18, 2026 07:19 PM
(MENAFN- Investor Brand Network) Oragenics (NYSE American: OGEN), a clinical-stage biopharmaceutical company focused on neurological therapeutics, today announced it will present and host one-on-one ...
EXCLUSIVE: Oragenics Completes Key FDA-Recognized Study For Concussion Drug Candidate
Tuesday, October 08, 2024 12:30 AM
On Tuesday, Oragenics Inc. (NYSE:OGEN) said it has completed a key study for its new concussion drug, ONP-002. What Happened: A recent study shows that the drug successfully targets areas inside the ...
OGEN historical stock data
date open high low close volume
12/08/26 0.524 0.55 0.5226 0.5363 13,494
11/08/26 0.5201 0.549 0.5106 0.5489 31,022
10/08/26 0.55 0.5624 0.5041 0.548 29,900
07/08/26 0.55 0.5501 0.5443 0.5499 13,933
06/08/26 0.54 0.55 0.5385 0.5435 7,875
05/08/26 0.541 0.5603 0.53 0.54 11,384
04/08/26 0.52 0.56 0.494 0.55 23,302
03/08/26 0.50 0.5293 0.50 0.5293 41,082
31/07/26 0.505 0.51 0.4899 0.50 34,534
30/07/26 0.5028 0.5028 0.4801 0.4902 15,739
Quote Details
52wk Low:0.48
52wk High:1.45
Vol:13.49K
Avg Vol(3m):581.1K
1Y Chng:-52.05%
1M Chng:-11.52%
Add to Watch List
More Information
Index NYSE AMEX Composite
Market Cap. 2.38M